Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6826 to 6840 of 8935 results

  1. VitalPAC for assessing vital signs of patients in hospital (MIB79)

    This advice has been updated and replaced by NICE medtech innovation briefing 205.

  2. UrgoStart for chronic wounds (MIB82)

    This advice has been updated and replaced by NICE medical technologies guidance 42.

  3. Absorb Bioresorbable Vascular Scaffold system for coronary artery disease (MIB84)

    NICE withdrew this medtech innovation briefing in November 2017 after the company stopped manufacturing Absorb because of low uptake. Some UK hospitals continue to use the technology in ongoing clinical studies.

  4. TheraSphere for treating operable and inoperable hepatocellular carcinoma (MIB62)

    This medtech innovation briefing has been updated and replaced by NICE technology appraisal guidance 688.

  5. SIR-Spheres for treating inoperable hepatocellular carcinoma (MIB63)

    This medtech innovation briefing has been updated and replaced by NICE technology appraisal guidance 688.

  6. Transanal total mesorectal excision of the rectum (IPG514)

    This guidance has been updated and replaced by NICE HealthTech guidance 603.

  7. Mepilex Border dressings for preventing pressure ulcers (MIB124)

    This advice has been updated and replaced by NICE medical technologies guidance 40.

  8. Health app: Sleepio for adults with poor sleep (MIB129)

    This advice has been updated and replaced by NICE healthtech guidance 624.

  9. Health app: ChatHealth communication platform in school nursing services (MIB130)

    The health app briefing on ChatHealth communication platform in school nursing services has been withdrawn.

  10. Curos disinfecting cap for needleless connectors (MIB143)

    This advice has been updated and replaced by NICE medical technologies guidance 44.

  11. QAngio XA 3D/QFR imaging software for assessing coronary obstructions (MIB146)

    This advice has been updated and replaced by NICE healthtech guidance 571.